Exelixis, Inc. (EXEL)
43.84
-0.20
(-0.44%)
USD |
NASDAQ |
Dec 31, 09:55
Exelixis Market Cap: 11.76B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 547.83M |
| ADMA Biologics, Inc. | 4.355B |
| Aldeyra Therapeutics, Inc. | 309.84M |
| Neurocrine Biosciences, Inc. | 14.07B |
| Axsome Therapeutics, Inc. | 8.679B |
Market Cap Related Metrics
| PE Ratio | 18.46 |
| PS Ratio | 5.483 |
| PEG Ratio | 0.3593 |
| Price to Book Value | 5.441 |
| Price to Free Cash Flow | 16.09 |
| Price | 43.84 |
| Earnings Yield | 5.42% |
| PEGY Ratio | 0.3593 |
| Operating PE Ratio | 15.30 |
| Normalized PE Ratio | 18.07 |